intravenous glutathione randomized controlled trial parkinson's disease Stem cells strike back: advancements in Alzheimer's and treatment and modeling efforts from 2019 to 2024 Parkinson's Disease - 2025 -

(6) Therapeutic efficacy is highly time sensitive, with optimal outcomes occurring prior to completion of the aging process and markedly reduced oxime responsiveness after the post-aging window

Nano-SiO2 can trigger malignant transformation and induce global DNA hypomethylation in human bronchial epithelial cells

Huangqin Decoction significantly alleviated colitis in mice, reducing body weight loss, disease activity, colon shortening, tissue damage, and levels of TNF-a, IL-6, IL-1, and COX-2 induced by DSS treatment

Surface-modified liposomal in-situ nasal gel enhances brain targeting of Berberine hydrochloride for alzheimers therapy: optimization and in vivo studies